Found: 9
Select item for more details and to access through your institution.
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
- Published in:
- International Journal of Rheumatic Diseases, 2020, v. 23, n. 4, p. 549, doi. 10.1111/1756-185X.13792
- By:
- Publication type:
- Article
Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 3, p. 434, doi. 10.1111/1756-185X.13387
- By:
- Publication type:
- Article
An elderly man with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) without neuropsychiatric sequelae.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2239, doi. 10.1093/rheumatology/kead579
- By:
- Publication type:
- Article
Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3614, doi. 10.1093/rheumatology/keab953
- By:
- Publication type:
- Article
T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3854, doi. 10.1093/rheumatology/keab935
- By:
- Publication type:
- Article
Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin‐2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 1, p. 132, doi. 10.1002/art.41457
- By:
- Publication type:
- Article
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 5, p. 1303, doi. 10.1007/s40744-024-00707-9
- By:
- Publication type:
- Article
Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02771-4
- By:
- Publication type:
- Article